97 related articles for article (PubMed ID: 17353644)
1. [A recurrent ovarian cancer patient who achieved a complete response following irinotecan plus CDDP therapy].
Kawashima T; Murakami H; Kanamori T; Nakamura Y
Gan To Kagaku Ryoho; 2007 Mar; 34(3):461-3. PubMed ID: 17353644
[TBL] [Abstract][Full Text] [Related]
2. [A case of papillary adenocarcinoma of the ovary that responded favorably to irinotecan hydrochloride and cisplatin after the administration of paclitaxel and carboplatin].
Shimoya K; Kunishige I; Okuno Y; Hayashi S; Komura H; Arimoto Y; Otsuki Y
Gan To Kagaku Ryoho; 2001 Jun; 28(6):845-8. PubMed ID: 11432356
[TBL] [Abstract][Full Text] [Related]
3. Chronic administration of single weekly paclitaxel in heavily pretreated ovarian cancer patients.
Yamamoto K; Oogi S; Inoue H; Kudoh K; Kita T; Kikuchi Y
Curr Med Chem; 2004 Feb; 11(4):425-8. PubMed ID: 14965223
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer.
Polyzos A; Kosmas C; Toufexi H; Malamos N; Lagadas A; Kosmidis C; Ginopoulos P; Ziras N; Kandilis K; Georgoulias V
Anticancer Res; 2005; 25(5):3559-64. PubMed ID: 16101180
[TBL] [Abstract][Full Text] [Related]
5. [A case of platinum-resistant, recurrent ovarian clear cell adenocarcinoma successfully treated with irinotecan (CPT-11) and paclitaxel (PTX) chemotherapy].
Konishi H; Takehara K; Okame S; Yamamoto Y; Kojima A; Shiroyama Y; Yokoyama T; Nogawa T
Gan To Kagaku Ryoho; 2014 Nov; 41(11):1437-9. PubMed ID: 25434451
[TBL] [Abstract][Full Text] [Related]
6. [Combination of irinotecan hydrochloride (CPT-11) and cisplatin as a new regimen for patients with advanced ovarian cancer].
Sugiyama T; Nishida T; Kataoka A; Imaishi K; Komai K; Ushijima K; Hasuo Y; Ookura N; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Sep; 48(9):827-34. PubMed ID: 8841050
[TBL] [Abstract][Full Text] [Related]
7. Complete remission of ovarian small cell carcinoma treated with irinotecan and cisplatin: a case report.
Saitoh-Sekiguchi M; Nakahara K; Kojimahara T; Ohta T; Kawagoe J; Ohnuki T; Hayasaka T; Motoyama T; Kurachi H
Anticancer Res; 2007; 27(4C):2685-7. PubMed ID: 17695433
[TBL] [Abstract][Full Text] [Related]
8. [Promising new drugs for gynecological cancer].
Yakushiji M; Sugiyama T; Ushijima K
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1932-7. PubMed ID: 9350238
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of clinical study of irinotecan and cisplatin for recurrent ovarian cancer].
Yahagi N; Kobayashi Y; Ohara T; Kondo H; Suzuki N; Kiguchi K; Ishizuka B
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2583-6. PubMed ID: 20009459
[TBL] [Abstract][Full Text] [Related]
10. Pilot study evaluating the efficacy and toxicity of irinotecan plus oral etoposide for platinum- and taxane-resistant epithelial ovarian cancer.
Nishio S; Sugiyama T; Shouji T; Yoshizaki A; Kitagawa R; Ushijima K; Kamura T
Gynecol Oncol; 2007 Aug; 106(2):342-7. PubMed ID: 17499346
[TBL] [Abstract][Full Text] [Related]
11. [A case of ovarian cancer in which a remarkable effect was seen with intrathoracic administration of CDDP and CPT-11].
Tokumitsu S; Oka H; Nozaki A; Kanazawa T; Mukohara Y; Matsubara M; Matsushita K; Tsunashima T
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2237-8. PubMed ID: 19106582
[TBL] [Abstract][Full Text] [Related]
12. Third-line chemotherapy with paclitaxel, irinotecan hydrochloride and cisplatin for recurrent gastric cancer: a case report.
Takahashi N; Suzuki H; Iwabuchi S; Yamazaki Y; Yanaga K
Hepatogastroenterology; 2005; 52(61):326-8. PubMed ID: 15783061
[TBL] [Abstract][Full Text] [Related]
13. [Successful optimal debulking surgery following chemotherapy combined with irinotecan hydrochloride and cisplatin for advanced clear cell carcinoma of the ovary].
Hirakawa H; Futagami M; Yokoyama Y; Hakamada K; Mizunuma H
Gan To Kagaku Ryoho; 2011 May; 38(5):857-60. PubMed ID: 21566454
[TBL] [Abstract][Full Text] [Related]
14. Case of pure ovarian squamous cell carcinoma resistant to combination chemotherapy with paclitaxel and carboplatin but responsive to monotherapy with weekly irinotecan.
Nakamura Y; Kamei T; Shinagawa M; Sakamoto Y; Miwa I
J Obstet Gynaecol Res; 2015 May; 41(5):809-12. PubMed ID: 25511544
[TBL] [Abstract][Full Text] [Related]
15. Weekly docetaxel for patients with platinum/paclitaxel/irinotecan-resistant relapsed ovarian cancer: a phase I study.
Terauchi F; Hirano T; Taoka H; Masaki K; Yamamoto Y; Ogura H; Kubo H
Int J Clin Oncol; 2003 Dec; 8(6):348-51. PubMed ID: 14663635
[TBL] [Abstract][Full Text] [Related]
16. Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer.
Naniwa J; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Shimada M; Shimogai R; Kawaguchi W; Sato S; Terakawa N
Int J Gynecol Cancer; 2007; 17(1):76-82. PubMed ID: 17291235
[TBL] [Abstract][Full Text] [Related]
17. Discordance of clinical symptoms and electrophysiologic findings in taxane plus platinum-induced neuropathy.
Pan Y; Kao MS
Int J Gynecol Cancer; 2007; 17(2):394-7. PubMed ID: 17362318
[TBL] [Abstract][Full Text] [Related]
18. [Three successful cases with CPT-11 + CDDP chemotherapy where S-1 failed to respond to recurrent gastric cancer].
Handa R; Iijima S; Doi T; Oshima K; Hoshi M; Makari Y; Miyake Y; Oshima S; Kato T; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2007 Nov; 34(12):2108-10. PubMed ID: 18219914
[TBL] [Abstract][Full Text] [Related]
19. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
20. [A case of advanced ovarian carcinosarcoma that responded remarkably to neoadjuvant chemotherapy of combined CPT-11 and CDDP].
Takami M; Idei T; Nakayama Y; Ohta H; Fukai H; Matsumoto H; Togo Y; Sakamoto H; Yamamoto T; Satoh K
Gan To Kagaku Ryoho; 2002 Feb; 29(2):305-8. PubMed ID: 11865639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
